Research Interests
The goal of the Reitman Lab is to make discoveries that guide the design of improved treatment strategies for children and adults with brain tumors. The Reitman Lab is based in the Department of Radiation Oncology and the team works closely with the faculty and staff in the Preston Robert Tisch Brain Tumor Center at Duke, the Department of Neurosurgery and the Duke Cancer Institute.
Selected Grants
Role of ATRX deficiency as a determinant of topoisomerase 1 inhibitor sensitivity in high grade gliomas
ResearchCo Investigator · Awarded by American Cancer Society, Inc. · 2025 - 2028Modulation of STING to enhance the efficacy of treatments for diffuse midline glioma
ResearchPrincipal Investigator · Awarded by Alex's Lemonade Stand · 2024 - 2028Enhancing the efficacy of Radiation Therapy for brainstem glioma by targeting ATM
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027Duke ACS Institutional Research Grant
ResearchSignificant Contributor · Awarded by American Cancer Society, Inc. · 2024 - 2026Exploring synthetic lethality with a novel very high energy electron FLASH radiation beam
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2026A programmable, cell type-specific, RNA-based tool to treat diffuse intrinsic pontine glioma (DIPG)
ResearchCollaborator · Awarded by B*Cured · 2023 - 2024Dissecting mechanisms of radioresistance associated with p53 mutations in DIPG
ResearchPrincipal Investigator · Awarded by Chadtough Defeat DIPG Foundation · 2022 - 2024Identifying brainstem glioma subtypes that can be radiosensitized by ATM inhibition
ResearchPrincipal Investigator · Awarded by Pediatric Brain Tumor Foundation · 2019 - 2023Image-Guided Radiation Therapy System for Small Animals
EquipmentMinor User · Awarded by National Institutes of Health · 2021 - 2022Enhancing the efficacy of radiation therapy for brainstem gliomas
ResearchPI-Fellow · Awarded by St. Baldrick's Foundation · 2020 - 2022Enhancing the efficacy of radiation therapy for DIPG
ResearchPrincipal Investigator · Awarded by Michael Mosier Defeat DIPG Foundation · 2020 - 2021Prioritizing PPM1D mutations as a target for new DIPG therapies
ResearchPrincipal Investigator · Awarded by Michael Mosier Defeat DIPG Foundation · 2019 - 2019Generation of a genetically-modified microorganism for adipic acid production
ResearchPrincipal Investigator · Awarded by North Carolina Biotechnology Center · 2014 - 2015External Relationships
- CURE childhood cancer
- Eisai Pharmaceuticals
- Genetron Health
- National Institute of Health (NIH)
- Oakstone Publishing CME
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.